Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx

Clinical and Translational Oncology

Volumn 15, Issue 5, 2013, Pages 358-363

  Mera Menendez F ^a   Hinojar Gutierrez A ^a   Rojas, M Guijarro ^a   De Gregorio, J García ^a   Mera Menendez E ^b   Sanchez J J ^c   Quintanilla, M ^c   Cerezo, L ^a   Gamallo, C ^a,d  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Glottic cancer; HIF 1; HIF 1alpha; Laryngeal cancer; Polymorphism

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; ADVANCED CANCER; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENETIC POLYMORPHISM; HAPLOTYPE MAP; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SECOND CANCER; GENETICS; GENOTYPE; GLOTTIS; LARYNX TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOTYPE; GLOTTIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 84885431360     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0930-z     Document Type: Article

References (29)

1. Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer incidence in five continents: vol. I, to VIII. IARC Cancer Base, No 7, Lyon
2. Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M (2005) Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 41: 683-693
3. Bartsch H, Dally H, Popanda O, Risch A, Schmezer P (2007) Genetic risk profiles for cancer susceptibility and therapy response. Recent Results Cancer Res 174: 19-36
4. Vaupel P, Mayer A, Höckel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381: 335-354
5. Acker T, Plate KH (2002) A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J Mol Med 80: 562-575
6. Hirota K, Semenza G (2006) Regulation of angiogénesis by hypoxia-inducible factor I. Crit Rev Oncol Hematol 59: 15-26
7. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K (2003) Hypoxiainducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24: 1779-1783
8. Secades P, Rodrigo J, Hermsen M, Alvarez C, Suarez C, Chiara MD (2009) Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas. Genes Chromosom Cancer 48: 441-454
9. Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, Maher ER (2001) The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Oncogene 20: 5067-5074
10. Zhao T, Lv J, Zhao J, Nzekebaloudou M (2009) Hypoxia inducible factor-1 alpha gene polymorphisms and cancer risk: a meta-analysis. J Exp Clin Cancer Res 28: 159
11. Cancer, American Join Committee on Cancer/International Union Against. American Join Committee on Cancer (2002) 6th Edition. http://www. cancerstaging.org/
12. Warren S, Gates O (1932) Multiple malignant tumors: a survey of literature and statistical study. Am J Cancer 51: 1358-1414
13. Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P (2006) Association between ulcerative growth and hypoxia inducible factor-1 alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45: 833-840
14. Hardy GH (1908) Mendelian proportions in a mixed population. Science 28: 49-50
15. Weinberg W (1908) Ü ber den Nachweis der Vererbung beim Menschen. Jahreshefle des Vereins für vaterländische Naturkunde in Württemberg 64: 368-382
16. HapMap Project (2007) CEPH population. http://www.ncbi.nih.gov/SNP/ snpref.cgi?rs=11549465
17. HapMap Project (2007) CEPH population. http://www.ncbi.nih.gov/SNP/ snpref.cgi?rs=11549467
18. Bartsch H, Hietanen E (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect 104: 569-577
19. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O (2009) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERC6 and RAD23B but not polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125: 1431-1439
20. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population based assessment of cancer risk in first-degree relative of cancer probands. J Natl Cancer Inst 86: 1600-1608
21. Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA (1996) Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ 313: 716-721
22. Cui Y, Morgenstern H, Greenland S et al (2006) Polymorphism of xeroderma pigmentosum group G and the risk of lung cancer and squamous cell carcinoma of the oropharynx, larynx and esophagus. Int J Cancer 118: 714-720
23. Sturgis EM, Wei Q (2002) Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr Opin Oncol 14: 310-317
24. Katsuta M, Miyashita M, Makino H et al (2005) Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 78: 123-130
25. Batmunkh E, Shimada M, Morine Y et al (2010) Expression of hypoxia inducible factor -1 alpha (HIF-1alpha) in patients with gallbladder carcinoma. Int J Clin Oncol 15: 59-64
26. Aebersold DM, Burri P, Beer KT et al (2001) Expression of hypoxia inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61: 2911-2916
27. Lin PY, Yu CH, Wang JT, Chiang CP et al (2008) Expression of hypoxiainducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 37: 18-25
28. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C (2009) Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 16: 2351-2358
29. Chen MK, Chiou H, Su SC et al (2009) The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer. Oral Oncol 45: 222-226